Dabigatran etexilate Completed Phase 3 Trials for Percutaneous Coronary Intervention / Nonvalvular Atrial Fibrillation Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02164864Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI)